699彩票有没有广西快三:2019中国南京第八届药物化学大会

发布时间:2019-02-26 17:24:26浏览:71
2019年11月15日 — 11月17日,南京,南京国际博览中心

广西快3现场 www.qp2vh.cn 展会名称:2019中国南京第八届药物化学大会

举办时间:2019-11-15 — 2019-11-17

举办展馆: 南京国际博览中心

主办单位:江苏省药学会

承办单位:百奥泰国际会议(大连)有限公司

协办单位:

行业分类: 医药保健

展会地区: 江苏南京

展会简介

 
opening
 
Stream 0: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum
Part 3: Dialog with Masters
 
Stream 1: Emerging Drug Targets
Session 101: Bioactive Lipids & Liposomes
Session 102: Human Kinases and Phosphatases
Session 103: G-protein Coupled Receptors(GPCR)& Ion-Channels
Session 104: Nuclear Receptor & Nucleic Acids
Session 105: Human Genome Derived Proteins
Session 106: Nanoparticles
 
 
Stream 2: Drug Design and Screening
Session 201: Molecular Modeling and Drug Design
Session 202: Molecular Docking &Molecular Dynamics Simulations Studies
Session 203: Fragment-based Drug Design
Session 204: Computer-Aided Drug Design(CADD)
Session 205:QSAR/QSPR Modeling Methods
Session 206: High Throughput Screening(HTS)
Session 207: Combinatorial Chemistry
 
 
Stream 3: Discovery of Lead Compounds
Session 301: Discovery of Lead Compounds by the Active Ingredients of Natural Products.
  • ?     Plant Sources
  • ?     Animal Sources
  • ?     Microbial Sources
  • ?     Marine Drug Sources
Session 302: The Synthesis of Derivatives
  • Synthesis Pyrimidine Derivatives
  • the Synthesis of Thiazole Derivatives
 
 
Stream 4: Lead Compound Optimization and Structure Modification
 
Session 401: Leading Compound Structural Optimization Strategies to Improve Metabolic Stability by Altering Metabolic Pathways
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Backbone Modification
  • Bioisosterism
  • Prodrugs
Session 402: Structural Modification Strategies to Reduce the Risk of Drug Toxicity
Including
  • Blocking Metabolic Sites
  • Changing Metabolic Pathways
  • Reducing Vigilance Structural Reactivity
  • Bioisosterism
  • Prodrugs
Session 403: Improve Water Solubility by Chemical Modification
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Skeleton Modification
  • Bioisosterism
  • Prodrugs
Session 404: Several Commonly used Strategies to Improve the Permeability of Blood-Brain Barriers
include:
  • Increasing Fat Solubility
  • Reducing Hydrogen Bond Donors
  • Simplifying Molecules
  • Increasing Rigidity
  • Reducing Polar Surface Area
  • Removing Carboxyl Groups
  • Prodrugs
 
 

 
Stream 5: New Technologies, New Processes for Drug Synthesis
Session 501: Research Status and Development Trends of Drug Synthesis Technology at Home and Abroad
  • Acoustic Chemical Synthesis
  • Microwave Chemical Synthesis
  • Electrochemical Synthesis
  • Solid Phase Reaction
  • Shock Wave Chemical Synthesis
 
Session 502: Research on New Synthetic Methods and Synthetic Processes of Drugs
  • Synthesis of Hybrid Compounds
  • Axial Ligand Synthesis
  • Biomimetic Synthesis
  • Stereoselective Chemistry
  • Heterocyclic Chemistry
  • Asymmetric Methods
Session 503: Technical Evaluation, Development and Optimization of Green Process Routes for Major Drug Varieties
Session 504: Application of New Catalysts in Drug Synthesis
Session 505: Chiral Synthesis Technology (Chemical Method, Biological Transformation Method)
Session 506: Control and Optimization of Drug Crystallization Process
Session 507: New Technologies and Applications for Drug Separation , Purification and Extraction Method
Session 508: Comprehensive Technical Treatment Plan for Three0waste Pollution
 
 

 
Stream 6: ADMET in Medicinal Chemistry
Session 601: Pharmacology and Toxicology
Session 602: PK/PD Study in Medicinal Chemistry
Session 603: ADME Safety Assessment
 
 
 
 
 
Stream 7: Next Generation Drug Pipelines
Session 701: New Anticancer Drugs
Session 702: Design, Synthesis and Biological Evaluation of Antibacterial and Antifungal Agents
Session 703: Drugs against Diabetes, Obesity and other Metabolic Disorders/Syndrome
Session 704: Drugs for Treating Central Nervous System Diseases& Antipsychotic
Session 705: Drug Therapy for Anti-Inflammatory and Immune Diseases
Session 706: Small Molecule Drugs for Tuberculosis and Malaria
Session 707: Drug Treatment Pain & AChE Inhibitors
Session 708: Next Generation Cardiovascular Drugs
 
 

 
Stream 8: Macromolecular Medicinal Chemistry
Session 801: R&D of Macromolecular Drugs
  • Polypeptides
  • Proteins
  • Antibodies
  • Polysaccharides
  • Nucleic Acids
  • Vaccine
  • Growth Factor
  • Monoclonal Antibody
Session 802: Biomacromolecular Drug Targets
  • PD1
  • PD-L1
  • CTLA-4
  • LAG-3
Session 803: Biotechnology of Macromolecular Drugs
  • Genetic Engineering
  • Cell Engineering
  • Protein Engineering
  • Fermentation Engineering
Session 804: Macromolecular Drugs Therapy for Major Disease
  • AID/HIV
  • Tumor/ Cancer
  • Cardia-cerebrovascular Disease
  • Coronary heart disease/ CHD
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Hepatitis c
  • Cystic Fibrosis
  • Autoimmune Diseases
  • Rare Genetic Disease
 
 
 
 
Stream 9: Showtime Square
Part 1: Papers and Posters
Part 2: Exhibition
 
 
 
opening
 
Stream 0: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum
Part 3: Dialog with Masters
 
Stream 1: Emerging Drug Targets
Session 101: Bioactive Lipids & Liposomes
Session 102: Human Kinases and Phosphatases
Session 103: G-protein Coupled Receptors(GPCR)& Ion-Channels
Session 104: Nuclear Receptor & Nucleic Acids
Session 105: Human Genome Derived Proteins
Session 106: Nanoparticles
 
 
Stream 2: Drug Design and Screening
Session 201: Molecular Modeling and Drug Design
Session 202: Molecular Docking &Molecular Dynamics Simulations Studies
Session 203: Fragment-based Drug Design
Session 204: Computer-Aided Drug Design(CADD)
Session 205:QSAR/QSPR Modeling Methods
Session 206: High Throughput Screening(HTS)
Session 207: Combinatorial Chemistry
 
 
Stream 3: Discovery of Lead Compounds
Session 301: Discovery of Lead Compounds by the Active Ingredients of Natural Products.
  • ?     Plant Sources
  • ?     Animal Sources
  • ?     Microbial Sources
  • ?     Marine Drug Sources
Session 302: The Synthesis of Derivatives
  • Synthesis Pyrimidine Derivatives
  • the Synthesis of Thiazole Derivatives
 
 
Stream 4: Lead Compound Optimization and Structure Modification
 
Session 401: Leading Compound Structural Optimization Strategies to Improve Metabolic Stability by Altering Metabolic Pathways
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Backbone Modification
  • Bioisosterism
  • Prodrugs
Session 402: Structural Modification Strategies to Reduce the Risk of Drug Toxicity
Including
  • Blocking Metabolic Sites
  • Changing Metabolic Pathways
  • Reducing Vigilance Structural Reactivity
  • Bioisosterism
  • Prodrugs
Session 403: Improve Water Solubility by Chemical Modification
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Skeleton Modification
  • Bioisosterism
  • Prodrugs
Session 404: Several Commonly used Strategies to Improve the Permeability of Blood-Brain Barriers
include:
  • Increasing Fat Solubility
  • Reducing Hydrogen Bond Donors
  • Simplifying Molecules
  • Increasing Rigidity
  • Reducing Polar Surface Area
  • Removing Carboxyl Groups
  • Prodrugs
 
 

 
Stream 5: New Technologies, New Processes for Drug Synthesis
Session 501: Research Status and Development Trends of Drug Synthesis Technology at Home and Abroad
  • Acoustic Chemical Synthesis
  • Microwave Chemical Synthesis
  • Electrochemical Synthesis
  • Solid Phase Reaction
  • Shock Wave Chemical Synthesis
 
Session 502: Research on New Synthetic Methods and Synthetic Processes of Drugs
  • Synthesis of Hybrid Compounds
  • Axial Ligand Synthesis
  • Biomimetic Synthesis
  • Stereoselective Chemistry
  • Heterocyclic Chemistry
  • Asymmetric Methods
Session 503: Technical Evaluation, Development and Optimization of Green Process Routes for Major Drug Varieties
Session 504: Application of New Catalysts in Drug Synthesis
Session 505: Chiral Synthesis Technology (Chemical Method, Biological Transformation Method)
Session 506: Control and Optimization of Drug Crystallization Process
Session 507: New Technologies and Applications for Drug Separation , Purification and Extraction Method
Session 508: Comprehensive Technical Treatment Plan for Three0waste Pollution
 
 

 
Stream 6: ADMET in Medicinal Chemistry
Session 601: Pharmacology and Toxicology
Session 602: PK/PD Study in Medicinal Chemistry
Session 603: ADME Safety Assessment
 
 
 
 
 
Stream 7: Next Generation Drug Pipelines
Session 701: New Anticancer Drugs
Session 702: Design, Synthesis and Biological Evaluation of Antibacterial and Antifungal Agents
Session 703: Drugs against Diabetes, Obesity and other Metabolic Disorders/Syndrome
Session 704: Drugs for Treating Central Nervous System Diseases& Antipsychotic
Session 705: Drug Therapy for Anti-Inflammatory and Immune Diseases
Session 706: Small Molecule Drugs for Tuberculosis and Malaria
Session 707: Drug Treatment Pain & AChE Inhibitors
Session 708: Next Generation Cardiovascular Drugs
 
 

 
Stream 8: Macromolecular Medicinal Chemistry
Session 801: R&D of Macromolecular Drugs
  • Polypeptides
  • Proteins
  • Antibodies
  • Polysaccharides
  • Nucleic Acids
  • Vaccine
  • Growth Factor
  • Monoclonal Antibody
Session 802: Biomacromolecular Drug Targets
  • PD1
  • PD-L1
  • CTLA-4
  • LAG-3
Session 803: Biotechnology of Macromolecular Drugs
  • Genetic Engineering
  • Cell Engineering
  • Protein Engineering
  • Fermentation Engineering
Session 804: Macromolecular Drugs Therapy for Major Disease
  • AID/HIV
  • Tumor/ Cancer
  • Cardia-cerebrovascular Disease
  • Coronary heart disease/ CHD
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Hepatitis c
  • Cystic Fibrosis
  • Autoimmune Diseases
  • Rare Genetic Disease
 
 
 
 
Stream 9: Showtime Square
Part 1: Papers and Posters
Part 2: Exhibition
 
 
Joint Events-1
 
Stream 10: Joint Events
Event 1 : BIT's 17th Annual Congress of International Drug Discovery Science and Technology-China
Event 2 : BIT's 9th Annual Symposium of Drug Delivery Systems
Event 3 : BIT's 1st Annual World Congress of  Microbiome
Event 4 : BIT's 1st World Congress of Medical Imaging
 
 
Joyful Commune B
 
Stream 11: Joyful Commune
Activity 1: Pre-conference Ice-Breaking Party
Activity 2: Welcome Banquet and Art Performance
Activity 3: Industrial Sponsored Cocktail Party
Activity 4: Lecture Tours to Campus
Activity 5: Field Trip to Industrial Park and Companies
Activity 6: Local Cultural Tours
 
 
 
Stream 10: Joint Events
Event 1 : BIT's 17th Annual Congress of International Drug Discovery Science and Technology-China
Event 2 : BIT's 9th Annual Symposium of Drug Delivery Systems
Event 3 : BIT's 1st Annual World Congress of  Microbiome
Event 4 : BIT's 1st World Congress of Medical Imaging
 
 
Joyful Commune B
 
Stream 11: Joyful Commune
Activity 1: Pre-conference Ice-Breaking Party
Activity 2: Welcome Banquet and Art Performance
Activity 3: Industrial Sponsored Cocktail Party
Activity 4: Lecture Tours to Campus
Activity 5: Field Trip to Industrial Park and Companies
Activity 6: Local Cultural Tours
 
 

参展范围

药物化学方向

参展费用

联系方式

Tel: 0086-0411-84799609-819
Email: [email protected]
Email: [email protected]
  • 端午节全国天气:晴雨相间 南方迎梅雨季 2019-05-26
  • (山西)报送参评中国新闻奖媒体融合奖公示 2019-05-26
  • 广州整治校外培训机构:禁止超纲教学等行为 2019-05-22
  • 一二线城市土地出让冰火两重天 2019-05-22
  • 专家研讨少年杨蒙诗集《找》:保持率真 探索更宽广的道路 2019-05-22
  • 吴为山新书《雕塑的世界》发布 2019-05-19
  • 家装行业猫腻:“低价全包”变身“加价全包” 2019-05-19
  • 中科大最新成果:二氧化碳“变身”多碳醇燃料 2019-05-15
  • iOS11.4又出问题,iPhone电池耗电太快! 2019-05-15
  • 丁霞、颜妮入选国家队 靠勤奋与担当 2019-05-12
  • 北京市下发文件 要求做好人民网网民留言办理工作 2019-05-08
  • 回复@艾鸣1:你的老蚕暴露无遗,还好意思笑?这个帖子会成为你终身的耻辱! 2019-05-08
  • 最美天鹅湖!三门峡黄河湿地迎来上万只白天鹅 2019-05-07
  • 全国高考开展网上评卷 看老师怎么给高考卷打分 2019-05-06
  • 【理上网来·喜迎十九大】泰国副总理顾问相信十九大以后中国共产党的领导会更加卓越 2019-05-06
  • 203| 818| 543| 325| 871| 414| 691| 749| 991| 253|